EUVIMEDEUVIMED entdecken
Crossref

What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?

Amin Sharifan

Cochrane Clinical Answers · 27.04.2026

DOI: 10.1002/cca.4789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cochrane Clinical Answers, online erschienen am 27.04.2026. Verfasst von Amin Sharifan. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sharifan, A. (2026). What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.4789

Vancouver

Sharifan A. What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?. Cochrane Clinical Answers. 2026. doi:10.1002/cca.4789

BibTeX
@article{Sharifan2026,
  author = {Sharifan, Amin},
  title = {What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?},
  journal = {Cochrane Clinical Answers},
  year = {2026},
  doi = {10.1002/cca.4789}
}
Kostenlos starten →